Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Clomipramine Hydrochloride Capsules USP, 25 mg, 50 mg, and 75 mg.Also enclosed press release on the same.
The above information is a part of company’s filings submitted to BSE.